Patna, Oct. 27 -- Bihar Minister and Bharatiya Janata Party (BJP) candidate from the Bankipur Assembly constituency, Nitin Nabin, on Monday praised Chief Minister Nitish Kumar for his welfare and deve... Read More
India, Oct. 27 -- A series of claims and counterclaims, including allegations of rape and pressure to fabricate postmortem reports, have emerged following a doctor's suicide in Maharashtra's Satara. I... Read More
India, Oct. 27 -- A series of claims and counterclaims, including allegations of rape and pressure to fabricate postmortem reports, have emerged following a doctor's suicide in Maharashtra's Satara. I... Read More
LUCKNOW, Oct. 27 -- Making derogatory remarks against the state government and the chief minister led to the suspension of a government doctor posted in Sultanpur district. An FIR was also booked agai... Read More
New Delhi, Oct. 27 -- Cyclone Montha is very likely to cross Andhra Pradesh coast between Machilipatnam and Kalingapatnam during the evening/night of October 28 "as a severe cyclonic storm", the India... Read More
LUCKNOW, Oct. 27 -- Making derogatory remarks against the state government and the chief minister led to the suspension of a government doctor posted in Sultanpur district. Doctor Bhaskar Prasad, who... Read More
India, Oct. 27 -- The Australia tour of 2025 did not go as planned for the Indian team when it came to performance as a team in the ODI series. Notably, Shubman Gill was handed over the captaincy in t... Read More
India, Oct. 27 -- Ola Electric Mobility Ltd. has scaled up its so-called Hyperservice initiative to open source its proprietary service infrastructure and technology, a move the company says will furt... Read More
Nigeria, Oct. 27 -- Governor Siminalayi Fubara of Rivers State is back in office after the six months' emergency rule declared by President Bola Tinubu in the state elapsed. The emergency rule follow... Read More
New Delhi, Oct. 27 -- Intellia Therapeutics has temporarily paused patient dosing and screening in its Phase 3 MAGNITUDE and MAGNITUDE-2 trials for nex-z, a CRISPR-based therapy for transthyretin amyl... Read More